BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25027393)

  • 1. Significance of estrogen receptor subtypes in breast tumorigenesis and progression.
    Sun W; Gu C; Xia M; Zhong G; Song H; Guo J
    Tumour Biol; 2014 Sep; 35(9):9111-7. PubMed ID: 25027393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.
    Jarzabek K; Koda M; Kozlowski L; Mittre H; Sulkowski S; Kottler ML; Wolczynski S
    Eur J Cancer; 2005 Dec; 41(18):2924-34. PubMed ID: 16289616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.
    Skliris GP; Leygue E; Watson PH; Murphy LC
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):1-10. PubMed ID: 18243688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metastases in breast cancer.
    Koda M; Sulkowski S; Kanczuga-Koda L; Surmacz E; Sulkowska M
    Oncol Rep; 2004 Apr; 11(4):753-9. PubMed ID: 15010868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
    Borgquist S; Holm C; Stendahl M; Anagnostaki L; Landberg G; Jirström K
    J Clin Pathol; 2008 Feb; 61(2):197-203. PubMed ID: 18223096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.
    Bozkurt KK; Kapucuoğlu N
    Pathol Res Pract; 2012 Mar; 208(3):133-9. PubMed ID: 22336175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and localization of estrogen receptor in human breast cancer and its clinical significance.
    Li L; Wang Q; Lv X; Sha L; Qin H; Wang L; Li L
    Cell Biochem Biophys; 2015 Jan; 71(1):63-8. PubMed ID: 25113640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.
    Järvinen TA; Pelto-Huikko M; Holli K; Isola J
    Am J Pathol; 2000 Jan; 156(1):29-35. PubMed ID: 10623650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
    Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
    J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of interactions between ER alpha and ER beta and lymph node status in breast cancer cases.
    Han SJ; Guo QQ; Wang T; Wang YX; Zhang YX; Liu F; Luo YX; Zhang J; Wang YL; Yan YX; Peng XX; Yan YX; Ling R; He Y
    Asian Pac J Cancer Prev; 2013; 14(10):6081-4. PubMed ID: 24289629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
    Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
    BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
    Green AR; Young P; Krivinskas S; Rakha EA; Claire Paish E; Powe DG; Ellis IO
    Histopathology; 2009 Mar; 54(4):419-27. PubMed ID: 19309393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
    Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue.
    Evers NM; van de Klundert TM; van Aesch YM; Wang S; de Roos WK; Romano A; de Haan LH; Murk AJ; Ederveen AG; Rietjens IM; Groten JP
    Toxicol In Vitro; 2013 Sep; 27(6):1753-61. PubMed ID: 23680332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.
    Izadi P; Mehrdad N; Foruzandeh F; Reza NM
    Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
    Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness.
    Refaat B; Aslam A; Idris S; Almalki AH; Alkhaldi MY; Asiri HA; Almaimani RA; Mujalli A; Minshawi F; Alamri SA; AlHussain MI; Baltow BA; Alqasmi MH; Basfar GT; Alosaimi OM; Muhayya IA
    Front Endocrinol (Lausanne); 2023; 14():1187259. PubMed ID: 37206439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological and prognostic significance of ERα and ERβ expression in lung carcinomas: a tissue microarray study].
    Yang X; Xue LY; Liu Y; Guo L; Wen P; Lin DM
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):678-83. PubMed ID: 24332055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.